SCHEMBL3226035

SCHEMBL3226035

CCC1CCN(C(=O)O)C1=O

nearest known ligand 0.39

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
ACE P12821 6/20 0.39
CYP2C19 P33261 1/20 0.35
PER2 O15055 2/20 0.34
CRY2 Q49AN0 2/20 0.34
FAAH O00519 3/20 0.33
KCNH2 Q12809 1/20 0.32
NAAA Q02083 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23001009 0.89 ACE (0.41) ACECYP2C19PER2CRY2
SCHEMBL28017368 0.87 ACE (0.38) ACEFAAHKCNH2
SCHEMBL6338204 0.84 ELANE (0.38) ACECYP2C19FAAHKCNH2NAAA
SCHEMBL366968 0.81 KCNH2 (0.40) FAAHKCNH2NAAA
SCHEMBL532775 0.79 FAAH (0.40) ACEPER2CRY2FAAH
SCHEMBL7036607 0.78 PER2 (0.33) ACEPER2CRY2FAAH
SCHEMBL5597540 0.77 FAAH (0.51) ACEFAAH
SCHEMBL28055445 0.76 ACE (0.39) ACEFAAHKCNH2
SCHEMBL12341085 0.76 PDE4A (0.42)
Bicarbonate SCHEMBL29254334 0.76 ACE (0.49) ACECYP2C19PER2CRY2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3101407-B1 KIT AND METHOD FOR ELECTRON MICROSCOPE OBSERVATION JAPAN SCIENCE & TECH AGENCY (JP) 2023-03-08 EP disclosed
EP-2894185-B1 ORGANIC POLYMER THIN FILM, AND METHOD FOR PRODUCING SAME JAPAN SCIENCE & TECH AGENCY (JP) 2017-11-29 EP disclosed
US-20170282130-A1 ORGANIC POLYMER THIN MEMBRANE, AND METHOD FOR PRODUCING SAME JAPAN SCIENCE & TECH AGENCY (JP) 2017-10-05 US disclosed
CN-106999398-A Makeup removing lotion, sheet cosmetic and cosmetic method 株式会社漫丹 2017-08-01 CN disclosed
US-9687793-B2 Organic polymer thin membrane, and method for producing same JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2017-06-27 US disclosed
US-20150224452-A1 ORGANIC POLYMER THIN MEMBRANE, AND METHOD FOR PRODUCING SAME Japan Science and Technology Agency of Saitama 2015-08-13 US disclosed
EP-2894185-A1 ORGANIC POLYMER THIN FILM, AND METHOD FOR PRODUCING SAME Japan Science and Technology Agency (JP) 2015-07-15 EP disclosed
US-8637696-B2 Methods for preparing amides and amino acids WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2014-01-28 US disclosed
US-20130030210-A1 METHODS FOR PREPARING AMIDES AND AMINO ACIDS WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2013-01-31 US disclosed
US-8269039-B2 Amino acids and catalytic preparatory methods WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2012-09-18 US disclosed
US-20100035831-A1 ANTI-WRINKLE AGENT AND ADAM INHIBITOR SHISEIDO COMPANY, LTD. (JP) 2010-02-11 US disclosed
US-20090264676-A1 Amino acids and catalytic preparatory methods WARF - WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2009-10-22 US disclosed
US-6528068-B1 An oily material for cosmetic compositions which oily material is an N-long-chain acyl neutral amino acid ester containing a straight-chain or branched-chain, saturated or unsaturated acyl group having from 6 to 22 carbon atoms, where the AJINOMOTO CO., INC. (JP) 2003-03-04 US disclosed
EP-1142562-A1 HAIR DYE COMPOSITIONS Lion Corporation (JP) 2001-10-10 EP disclosed
US-6251878-B1 TREATING ULTRAVIOLET LIGHT-INDUCED SUPPRESSION OF IMMUNE RESPONSE OF SKIN OF ANIMAL BY CONTACTING SKIN WITH COMPOSITION COMPRISING TAMARIND SEED XYLOGLUCAN OLIGOSACCHARIDES BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2001-06-26 US disclosed
US-5880076-A PERSONAL PRODUCT OR DETERGENT COMPOSITION COMPRISING CYCLIC GLYCACARBAMATE AND/OR GLYCAUREA, SURFACTANT LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) 1999-03-09 US disclosed
US-5653970-A CLEANING COMPOUNDS; COSMETICS LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) 1997-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100035831-A1 ANTI-WRINKLE AGENT AND ADAM INHIBITOR MMP17, ADAM17, GLA ACE 293/4885CYP2C19 1867/4885PER2 3279/4885
US-20130030210-A1 METHODS FOR PREPARING AMIDES AND AMINO ACIDS DNPEP, PTMS, QPCT ACE 313/4885CYP2C19 2223/4885PER2 2580/4885
US-20090264676-A1 Amino acids and catalytic preparatory methods DNPEP, PREP, ENPEP ACE 265/4885CYP2C19 2378/4885PER2 2384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.